SacknerMA, EpsteinS, WannerA.Effects of beta adrenergic agonists aerosolized by freon propellant on tracheal mucus velocity and cardiac output. Chest1976;69:593–598.
2.
HughesJM, SealeJP, TempleDM. Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta adrenoceptor antagonists. Eur J Pharmacol1983;95:239–245.
3.
CochraneGM. Bronchial asthma and the role of beta-2 agonists. Lung1990;168(Suppl):66–70.
4.
SealeJP. Whither beta-adrenoceptor agonists in the treatment of asthma?Prog Clin Biol Res1988;263:367–377.
5.
WaldeckB, OlssonOAT, SvenssonL-A. New possibilities for the beta adrenoceptor agonists bronchodilator drugs. Agents Actions Suppl1988;23:55–68.
6.
JenT, FrazeeJS, SchwaetzMS, KaiserC.Adrenergic agents, 7: Synthesis and beta-adrenergic activity of several 2-pyrodyl ethanolamines. J Med Chem1977;20:1258–1262.
7.
LofdahlCG, SvedmyrN.Formoterol fumarate, a new beta-, adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. Allergy1989;44:264–271.
8.
MaloJL, CartierA, TrudeauC, GhezzoH, GontovnickL.Formoterol, a new inhaled beta-, adrenergic agonist, has a longer blocking effect than albuterol on hyper ventilation-induced bronchoconstriction. Am Rev Respir Dis1990;142:1147–1152.
9.
MaesenFP, SmeetsJJ, GubbelmansHL, ZweersPG. Formoterol in the treatment of nocturnal asthma. Chest1990;98:866–870.
10.
SykesAP, AyresJG. A study of the duration of the bronchodilator effect of 12 micrograms and 24 micrograms of inhaled formoterol and 200 micrograms inhaled salbutamol in asthma. Respir Med1990;84:135–138.
11.
HekkingPR, MaesenF, GreefhorstA, PrinsJ, TanY, ZweersP.Long term efficacy of formoterol compared to salbutamol. Lung1990;168(Suppl):76–82.
12.
AldonsPM. Can a new beta-agonist reduce the mortality of asthma?Lung1990;168(Suppl):186–191.
13.
CharpinD.Acute and long-term effectiveness of tulobuterol inhaler, a new beta-, agonist, in the treatment of asthma. Lung1990;168(Suppl):194–201.
14.
BrittainRT. Approaches to a long acting, selective beta-, adrenoceptor stimulant. Lung1990;168(Suppl):111–114.
15.
LofdahlCG. Basic pharmacology of new long-acting sympathomimetics. Lung1990;168(Suppl):18–21.
16.
TwentymanOP, FinnertyJP, HarrisA, PalmerJ, HolgateST. Protection against allergen-induced asthma by salmeterol. Lancet1990;336:1338–1342.
17.
UllmanA, HednerJ, SvedmyrN.Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis1990;142:571–575.
18.
LarssonS.Long-term studies on long-acting sympathomimetics. Lung1990;168(Suppl):22–24.
19.
BrittonM.A new long-acting beta 2 agonist, salmeterol: twelve month comparison with albuterol in asthmatic patients. Am Rev Respir Dis1991;143(4, Part 2):A649.
20.
FriedelHA, BrogdenRN. Bitolterol: a preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease. Drugs1988;35:22–41.
21.
SvenssonLA. Bambuterol, a bronchodilator prodrug with sustained action, enhances delivery of active drug to the lung. Agents Action Suppl1988;23:271–276.
22.
GnosspeliusY, PerssonG, EklundhG, NybergL.Bambuterol, a new terbutaline prodrug with prolonged effect duration. Respiration1984;46(1, Suppl):84–94.
23.
AlbrechtR, HeindlJ, LogeO.Beta-, agonists containing metabolically labile groups. II. The influence of ester groups in the aryl system. Eur J Med Chem1985;20:57–60.
24.
FracchiaC, Della TorreM, AmbrosinoN, MontagnaT, RampullaC.A study on the proper dosage of procaterol in bronchial asthma (abstract). Am Rev Respir Dis1991;143(4, Part 2):A649.
25.
TantucciC, BumiB, DottoriniML, MalerbaM, PecciniF, GurrieriG, SorbiniCA, GrassiV.Acute ventilatory and gas-exchange effects of a new beta-agonist, broxaterol, in asthmatics. Int J Clin Pharmacol Res1990;10:183–189.
26.
ZimentI.Risk/benefit ratio of long term treatment with beta-, adrenoceptor agonists. Lung1990;168(Suppl):168–176.
27.
LofdahlCG, BengtssonB, SvedmyrK, SvedmyrN.Two new beta-, adrenoceptor agonists, D2343 and QH25, studied in asthmatic patients. Allergy1982;37:351–357.
28.
WoolcockAJ, SalomeCM, KeenaVA. Therapy for bronchial hyperreactivity: reducing the severity of bronchial hyperresponsiveness. Am Rev Respir Dis1991;143(3, Part 2):S75–S77.
29.
KraanJ, KoeterGH, MarkTW, SluiterHJ, de VriesK.Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budenosicle and terbutaline. J Allergy Clin Immunol1985;76:628–636.
30.
VathenenAS, KnoxAJ, HigginsBG, BrittonJR, TattersfieldAE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet1988;1:554–558.
